[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637174":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":55,"collaborators":26,"id":58,"slug":26,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":26,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":26,"enrollmentInfo":67,"targetDuration":26,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":26,"overallStatus":42,"whyStopped":26,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"University of Saskatchewan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Creatine","EXPERIMENTAL","10 grams per day creatine",[13],"Dietary Supplement: Dietary supplementation during a 12 week resistance-training program (creatine)",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Placebo (maltodextrin)",[19],"Dietary Supplement: Dietary supplementation during a 12 week resistance-training program (placebo)",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Dietary supplementation during a 12 week resistance-training program (creatine)","creatine supplementation",[9],null,{"type":22,"name":28,"description":15,"armGroupLabels":29,"otherNames":26},"Dietary supplementation during a 12 week resistance-training program (placebo)",[15],[31],{"name":32,"affiliation":5,"role":33},"Philip Chilibeck, PhD","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":26,"email":39},"Philip D Chilibeck, PhD","CONTACT","306-966-1072","phil.chilibeck@usask.ca",[41],{"facility":5,"status":42,"city":43,"state":44,"zip":45,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Saskatoon","SK - Saskatchewan","S7N 5B2","Canada",{"type":48,"coordinates":49},"Point",[50,51],-106.66892,52.13238,{"lat":51,"lon":50},[54],{"name":36,"role":37,"phone":38,"phoneExt":26,"email":39},{"type":33,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Phil Chilibeck","Professor","100637174",false,"NCT07625202","Creatine Supplementation During GLP-1a Therapy","A Pilot Study on Creatine Supplementation During Resistance-training for Prevention of Lean Tissue Mass Loss During GLP-1 Receptor Agonist Therapy","Inclusion Criteria:\n\n* Starting GLP-1 agonist therapy\n* 18 years of age or older\n\nExclusion Criteria:\n\n* Positive answers to a screening questionnaire for physical activity safety (the Get Active Questionnaire)",true,"ALL","18 Years",{"count":68,"type":69},40,"ESTIMATED","INTERVENTIONAL",[72],"NA","GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.",[75],"Sarcopenia","2026-05-30",{"date":78,"type":79},"2026-06-04","ACTUAL",{"date":81,"type":79},"2026-05-25",{"date":83,"type":69},"2027-12-31",{"name":5,"class":6},1]